Acta Diabetologica

, Volume 45, Issue 3, pp 157–165 | Cite as

Screening for biomarkers predictive of gestational diabetes mellitus

  • Harry M. Georgiou
  • Martha Lappas
  • George M. Georgiou
  • Adinda Marita
  • Valerie J. Bryant
  • Richard Hiscock
  • Michael Permezel
  • Zeinab Khalil
  • Gregory E. Rice
Original Article


Screening for glucose intolerance during pregnancy provides an opportunity to offer management to those women diagnosed with gestational diabetes mellitus. However, there is a need to diagnose gestational diabetes early to minimize exposure of the developing fetus to suboptimal conditions and prevent perinatal complications and their sequelae. The purpose of this study was to identify potential biomarkers for impending gestational diabetes that appear in the plasma before impaired glucose tolerance. Pregnant women were prospectively recruited to the study and blood was collected at the first antenatal visit and at the time of routine oral glucose tolerance test. Women diagnosed with gestational diabetes were matched with an equal number of normal pregnant (control) women. Biomarkers under investigation included endocrine and metabolic hormones, cytokines and chemokines, and surrogate markers of oxidative stress. Compared to controls, women with gestational diabetes exhibited elevated plasma insulin and reduced plasma adiponectin concentrations at 28 weeks gestation. Significant differences in insulin and adiponectin concentrations were also observed in plasma at 11 weeks gestation. Bivariate logistic regression analysis showed that both insulin and adiponectin are associated with subsequent development of gestational diabetes. Plasma insulin and adiponectin concentrations, when measured at 11 weeks, may be predictive of impending gestational diabetes. Further studies are warranted to determine the reliability of these biomarkers.


Gestational diabetes mellitus Insulin Adiponectin Biomarkers Prediction 


  1. 1.
    Beischer NA, Oats JN, Henry OA, Sheedy MT, Walstab JE (1991) Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia. Diabetes 40(Suppl 2):35–38PubMedGoogle Scholar
  2. 2.
    Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D (1998) Gestational diabetes mellitus—management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust 169:93–97PubMedGoogle Scholar
  3. 3.
    American College of Obstetricians and Gynecologists Committee on Practice Bulletins–Obstetrics (2001) ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol 98:525–538Google Scholar
  4. 4.
    Hod M, Merlob P, Friedman S, Schoenfeld A, Ovadia J (1991) Gestational diabetes mellitus. A survey of perinatal complications in the 1980s. Diabetes 40(Suppl 2):74–78PubMedGoogle Scholar
  5. 5.
    Van Assche FA, Aerts L, Holemans K (1992) Maternal diabetes and the effect for the offspring. Verh K Acad Geneeskd Belg 54:95–106 discussion 107–108PubMedGoogle Scholar
  6. 6.
    Silverman BL, Metzger BE, Cho NH, Loeb CA (1995) Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care 18:611–617PubMedCrossRefGoogle Scholar
  7. 7.
    Van Assche FA, Holemans K, Aerts L (2001) Long-term consequences for offspring of diabetes during pregnancy. Br Med Bull 60:173–182PubMedCrossRefGoogle Scholar
  8. 8.
    Mestman JH (1987) Follow-up studies in women with gestational diabetes mellitus. Springer-Verlag, New York, pp 191–198Google Scholar
  9. 9.
    O’Sullivan JB (1989) The Boston gestational diabetes studies: review and perspectives. Springer-Verlag, London, pp 287–294Google Scholar
  10. 10.
    Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4–7PubMedCrossRefGoogle Scholar
  11. 11.
    Evans JL, Maddux BA, Goldfine ID (2005) The molecular basis for oxidative stress-induced insulin resistances. Antioxid Redox Signal 7:1040–1052PubMedCrossRefGoogle Scholar
  12. 12.
    Federici M, Lauro R (2005) Review article: diabetes and atherosclerosis—running on a common road. Aliment Pharmacol Ther 22(Suppl 2):11–15PubMedCrossRefGoogle Scholar
  13. 13.
    Agarwal MM, Dhatt GS, Punnose J, Koster G (2005) Gestational diabetes: dilemma caused by multiple international diagnostic criteria. Diabet Med 22:1731–1736PubMedCrossRefGoogle Scholar
  14. 14.
    Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486PubMedCrossRefGoogle Scholar
  15. 15.
    Caliskan E, Kayikcioglu F, Ozturk N, Koc S, Haberal A (2004) A population-based risk factor scoring will decrease unnecessary testing for the diagnosis of gestational diabetes mellitus. Acta Obstet Gynecol Scand 83:524–530PubMedCrossRefGoogle Scholar
  16. 16.
    Sacks DA, Chen W, Wolde-Tsadik G, Buchanan TA (2003) Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Obstet Gynecol 101:1197–1203PubMedCrossRefGoogle Scholar
  17. 17.
    Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N (2003) Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract 62:47–53PubMedCrossRefGoogle Scholar
  18. 18.
    Bhattacharya SM (2004) Fasting or two-hour postprandial plasma glucose levels in early months of pregnancy as screening tools for gestational diabetes mellitus developing in later months of pregnancy. J Obstet Gynaecol Res 30:333–336PubMedCrossRefGoogle Scholar
  19. 19.
    Cypryk K, Czupryniak L, Wilczynski J, Lewinski A (2004) Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose. Acta Diabetol 41:5–8PubMedCrossRefGoogle Scholar
  20. 20.
    Nahum GG, Wilson SB, Stanislaw H (2002) Early-pregnancy glucose screening for gestational diabetes mellitus. J Reprod Med 47:656–662PubMedGoogle Scholar
  21. 21.
    Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R (2003) First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26:819–824PubMedCrossRefGoogle Scholar
  22. 22.
    Thadhani R, Wolf M, Hsu-Blatman K, Sandler L, Nathan D, Ecker JL (2003) First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. Am J Obstet Gynecol 189:171–176PubMedCrossRefGoogle Scholar
  23. 23.
    Ong CY, Lao TT, Spencer K, Nicolaides KH (2004) Maternal serum level of placental growth factor in diabetic pregnancies. J Reprod Med 49:477–480PubMedGoogle Scholar
  24. 24.
    Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA (2004) Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol 103:519–525PubMedGoogle Scholar
  25. 25.
    Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA (2004) Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 89:2306–2311PubMedCrossRefGoogle Scholar
  26. 26.
    Khan J, Brennand DM, Bradley N, Gao B, Bruckdorfer R, Jacobs M (1998) 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J 330:795–801PubMedGoogle Scholar
  27. 27.
    Mihaljevic B, Katusin-Razem B, Razem D (1996) The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med 21:53–63PubMedCrossRefGoogle Scholar
  28. 28.
    Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B (2004) Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 27:799–800PubMedCrossRefGoogle Scholar
  29. 29.
    Atalay M, Laaksonen DE (2002) Diabetes, oxidative stree and physical exercise. J Sport Sci Med 1:1–14Google Scholar
  30. 30.
    Perkins AV (2006) Endogenous anti-oxidants in pregnancy and preeclampsia. Aust N Z J Obstet Gynaecol 46:77–83PubMedCrossRefGoogle Scholar
  31. 31.
    Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, Rice GE (2004) Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 25:78–84PubMedCrossRefGoogle Scholar
  32. 32.
    Kirwan JP, Hauguel De Mouzon S, Lepercq J, Challier JC, Huston Presley L, Friedman JE, Kalhan SC, Catalano PM (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207–2213PubMedCrossRefGoogle Scholar
  33. 33.
    Lappas M, Permezel M, Rice GE (2004) Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 89:5627–5633PubMedCrossRefGoogle Scholar
  34. 34.
    Smirnakis KV, Plati A, Wolf M, Thadhani R, Ecker JL (2007) Predicting gestational diabetes: choosing the optimal early serum marker. Am J Obstet Gynecol 196:410.e1–410.e7CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Harry M. Georgiou
    • 1
    • 2
  • Martha Lappas
    • 1
    • 2
  • George M. Georgiou
    • 3
  • Adinda Marita
    • 1
  • Valerie J. Bryant
    • 2
  • Richard Hiscock
    • 2
  • Michael Permezel
    • 1
    • 2
  • Zeinab Khalil
    • 3
    • 4
  • Gregory E. Rice
    • 1
    • 5
  1. 1.Department of Obstetrics and GynecologyUniversity of MelbourneParkvilleAustralia
  2. 2.Mercy Perinatal Research CentreMercy Hospital for WomenHeidelberg WestAustralia
  3. 3.Department of Biochemistry and Molecular BiologyUniversity of MelbourneParkvilleAustralia
  4. 4.College of MedicineUniversity of SharjahSharjahUnited Arab Emirates
  5. 5.Translational ProteomicsBaker Medical Research InstituteMelbourneAustralia

Personalised recommendations